Evaluation of leech therapy in diabetic neuropathy of lower limbs

Phase 3

Recruiting

Conditions: Diabetic neuropathy.
Type 2 diabetes mellitus with diabetic neuropathy, unspecified
E11.40

Registration Number: IRCT20150927024228N3

Lead Sponsor: Kerman University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

Having informed consent
Age 30 years and above
Type 2 diabetes with the approval of an endocrinologist
Having diabetic neuropathy based on nerve and muscle tape
The patient should not use other drugs that are effective on neuropathy at the same time
No pregnancy
No breastfeeding
No other diseases that cause neuropathy such as alcohol, vitamin B12 deficiency, chemotherapy, kidney failure, nerve compression, autoimmune disease, infection, Guillain-Barre syndrome

Exclusion Criteria

Having a diabetic foot ulcer requires surgery
Use of anticoagulants such as heparin, warfarin, etc
Any coagulation disease
History of hospitalization due to cardiovascular disease
History of major mental disorders
Not taking painkillers, or common drugs for neuropathy treatment during the last month
Anemia

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Burning sensation. Timepoint: At the beginning of the study, days 15, 30 and 45 of the beginning of the study. Method of measurement: Using Visual Analogue Scale and Neurophathy Symptom Score questionnaires.;Intensity of pain. Timepoint: At the beginning of the study, days 15, 30 and 45 of the beginning of the study. Method of measurement: Using Visual Analogue Scale and Neurophathy Symptom Score questionnaires.;Tingling. Timepoint: At the beginning of the study, days 15, 30 and 45 of the beginning of the study. Method of measurement: Visual Analogue scale and neuropathy symptom score questionnaire.

Secondary Outcome Measures